Table 4.
Vitamin A group | Placebo group | Risk ratio (95% CI) | p value | |
---|---|---|---|---|
All infants (n=31 627)
| ||||
Death within 3 days of supplementation | 116 (0·73%) | 130 (0·82%) | 0·89 (0·7–1·15) | 0·378 |
| ||||
Infants with data for adverse events within 3 days (n=29 041)
| ||||
Examined bulging fontanelle | 21 (0·14%) | 20 (0·14%) | 1·05 (0·57–1·94) | 0·877 |
Fever | 174 (1·2%) | 179 (1·23%) | 0·97 (0·79–1·20) | 0·786 |
Vomiting | 26 (0·18%) | 17 (0·12%) | 1·53 (0·83–2·82) | 0·170 |
Diarrhoea | 3 (0·02%) | 5 (0·03%) | 0·60 (0·14–2·51) | 0·479 |
Inability to suck or feed | 30 (0·21%) | 29 (0·2%) | 1·03 (0·62–1·72) | 0·897 |
Convulsion | 0 (0%) | 5 (0·03%) | ·· | 0·031* |
Fisher’s exact test p value.